Time courses, multi-factor designs, paired samples, batches crossed with groups: running the default two-group pipeline can give conclusions that may not hold.
You have DE lists and a UMAP, but what you need is one cell subset, one pathway or one treatment effect.
A reviewer wants a different method, additional statistics, a validation cohort or extra figures, and the deadline is close.
Your own data plus public cohorts, transcriptome plus proteome or metabolome, or data from different platforms and batches.
Sent within one working day. Work starts only after you approve it, and delivery is checked against it item by item.
4 time points × 3 replicates; which genes change over time after treatment, and in what patterns.
Typically 7–10 working days
Six tumour single-cell samples; interest in T-cell subsets before and after treatment, with validation in a public cohort.
Typically 15–20 working days
Reviewer asks to redo differential analysis with batch correction, add GSEA and ROC curves for a diagnostic model; reply due in three weeks.
Typically 3–7 working days
These examples illustrate how plans are written; they are not client projects. Actual timeline and price are set in the written plan.
| Stage | Details |
|---|---|
| Data | FASTQ, BAM, count matrices, Seurat/h5ad, Cell Ranger/Space Ranger output, MS quantification tables, public accessions |
| Context | Sample sheet, the question, genes or pathways of interest, target journal, deadline |
| Process | Written plan → your approval → analysis → item-by-item senior review → delivery |
| Delivery | Report, publication figures (PDF/SVG/PNG), tables (Excel/CSV), re-runnable code and parameters, methods text |
| After delivery | Questions answered; revision analyses as agreed in the plan |
You will receive a written plan and quote within one working day.